Evidence map›Paper›PMID 33804307›Full record

ArticleJournal of clinical medicine2021

SARS-CoV-2 Is a Culprit for Some, but Not All Acute Ischemic Strokes: A Report from the Multinational COVID-19 Stroke Study Group.

Shima Shahjouei, Michelle Anyaehie, Eric Koza, Georgios Tsivgoulis, Soheil Naderi, Ashkan Mowla, Venkatesh Avula, Alireza Vafaei Sadr, Durgesh Chaudhary, Ghasem Farahmand and 7 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 3 pooled it
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 3 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Stroke Risk Related to Coronavirus Disease-2019: What Have We Learned?Critical care nursing clinics of North America · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Safety and Outcomes of Intravenous Thrombolytic Therapy in Ischemic Stroke Patients with COVID-19: CASCADE Initiative.Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2021
    Observational
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 10 institutions in 6 countries.

Shima ShahjoueiNeurology Department, Neuroscience Institute, Geisinger Health System, Danville, PA 17822, USA.
Michelle AnyaehieNeurology Department, Neuroscience Institute, Geisinger Health System, Danville, PA 17822, USA.
Eric KozaNeuroscience Institute, Geisinger Commonwealth School of Medicine, Scranton, PA 18510, USA.
Georgios TsivgoulisSecond Department of Neurology, "Attikon" University Hospital, National and Kapodistrian University of Athens, School of Medicine, 12462 Athens, Greece.
Soheil NaderiDepartment of Neurosurgery, Tehran University of Medical Sciences, Tehran 14155-6559, Iran.
Ashkan MowlaNeurology Department, Neuroscience Institute, Geisinger Health System, Danville, PA 17822, USA.
Venkatesh AvulaNeurology Department, Neuroscience Institute, Geisinger Health System, Danville, PA 17822, USA.ORCID 0000-0001-5141-1502
Alireza Vafaei SadrDepartment de Physique Theorique and Center for Astroparticle Physics, University Geneva, 1211 Geneva, Switzerland.
Durgesh ChaudharyNeurology Department, Neuroscience Institute, Geisinger Health System, Danville, PA 17822, USA.
Ghasem FarahmandIranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran 14155-6559, Iran.ORCID 0000-0001-9550-6511
Christoph GriessenauerNeurology Department, Neuroscience Institute, Geisinger Health System, Danville, PA 17822, USA.
Mahmoud Reza AzarpazhoohDepartment of Clinical Neurological Sciences, Western University, London, ON N6A 3K7, Canada.
Debdipto MisraSteele Institute of Health and Innovation, Geisinger Health System, Danville, PA 17822, USA.
Jiang LiDepartment of Molecular and Functional Genomics, Geisinger Health System, Danville, PA 17822, USA.
Vida AbediDepartment of Molecular and Functional Genomics, Geisinger Health System, Danville, PA 17822, USA.ORCID 0000-0001-7689-933X
Ramin ZandNeurology Department, Neuroscience Institute, Geisinger Health System, Danville, PA 17822, USA.
The Multinational Covid-Stroke Study Group
Geisinger Neuroscience Institute · USGeisinger Health System · USTehran University of Medical Sciences · IRBiocom · USGeisinger Commonwealth School of Medicine · USNational and Kapodistrian University of Athens · GRParacelsus Medical University · ATUniversity of Geneva · CHUniversity of Southern California · USWestern University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSARS-CoV-2 infected patients are suggested to have a higher incidence of thrombotic events such as acute ischemic strokes (AIS). This study aimed at exploring vascular comorbidity patterns among SARS-CoV-2 infected patients with subsequent stroke. We also investigated whether the comorbidities and their frequencies under each subclass of TOAST criteria were similar to the AIS population studies prior to the pandemic.

methodsThis is a report from the Multinational COVID-19 Stroke Study Group. We present an original dataset of SASR-CoV-2 infected patients who had a subsequent stroke recorded through our multicenter prospective study. In addition, we built a dataset of previously reported patients by conducting a systematic literature review. We demonstrated distinct subgroups by clinical risk scoring models and unsupervised machine learning algorithms, including hierarchical K-Means (ML-K) and Spectral clustering (ML-S).

resultsThis study included 323 AIS patients from 71 centers in 17 countries from the original dataset and 145 patients reported in the literature. The unsupervised clustering methods suggest a distinct cohort of patients (ML-K: 36% and ML-S: 42%) with no or few comorbidities. These patients were more than 6 years younger than other subgroups and more likely were men (ML-K: 59% and ML-S: 60%). The majority of patients in this subgroup suffered from an embolic-appearing stroke on imaging (ML-K: 83% and ML-S: 85%) and had about 50% risk of large vessel occlusions (ML-K: 50% and ML-S: 53%). In addition, there were two cohorts of patients with large-artery atherosclerosis (ML-K: 30% and ML-S: 43% of patients) and cardioembolic strokes (ML-K: 34% and ML-S: 15%) with consistent comorbidity and imaging patterns. Binominal logistic regression demonstrated that ischemic heart disease (odds ratio (OR), 4.9; 95% confidence interval (CI), 1.6-14.7), atrial fibrillation (OR, 14.0; 95% CI, 4.8-40.8), and active neoplasm (OR, 7.1; 95% CI, 1.4-36.2) were associated with cardioembolic stroke.

conclusionsAlthough a cohort of young and healthy men with cardioembolic and large vessel occlusions can be distinguished using both clinical sub-grouping and unsupervised clustering, stroke in other patients may be explained based on the existing comorbidities.

Indexed as

cerebrovascular disorderscluster analysiscomorbidityCOVID-19risk factorsSARS-CoV-2stroke

Identifiers

PMID33804307
PMCPMC7957755
OpenAlexW3133769718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.